Aubrey Capital Management Ltd / DC4
Aubrey Capital Management Ltd’s Dexcom Inc Position
Does Aubrey Capital Management Ltd own Dexcom Inc (DC4)? Not currently — the last reported position was 28.9K shares worth $4M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q4 2023
Shares
28.9K
% of Portfolio
+1.53%
Quarters Held
20
position exited
Position History DC4
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 28.9K | $4M | +1.53% |
| Q3 2023 | 29.5K | $2M | +1.40% |
| Q2 2023 | 44.5K | $6M | +3.75% |
| Q1 2023 | 48.3K | $6M | +3.25% |
| Q4 2022 | 48.3K | $5M | +4.38% |
| Q3 2022 | 51.9K | $4.2B | +3.58% |
| Q2 2022 | 56.2K | $4.2B | +3.37% |
| Q1 2022 | 15.4K | $8M | +4.51% |
| Q4 2021 | 20.4K | $11.0B | +4.28% |
| Q3 2021 | 20.4K | $11.2B | +3.52% |
| Q2 2021 | 20.4K | $8.7B | +2.54% |
| Q1 2021 | 21.9K | $7.9B | +2.22% |
| Q4 2020 | 21.9K | $8.1B | +2.02% |
| Q3 2020 | 21.9K | $9.0B | +2.80% |
| Q2 2020 | 22.3K | $9.1B | +4.05% |
| Q1 2020 | 34.3K | $9.3B | +5.72% |
| Q4 2019 | 37.9K | $8.3B | +4.70% |
| Q3 2019 | 34.5K | $5.2B | +3.15% |
| Q2 2019 | 23.5K | $3.5B | +1.68% |
| Q1 2019 | 19.3K | $2.3B | +1.10% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aubrey Capital Management Ltd’s full portfolio or all institutional holders of DC4.